$PFE Company News
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Audit: Medicare overpays for penis pumps 6:48 p.m. Jan. 14, 2014 - blogs.marketwatch.com
A contrarian take on the market’s correction 12:48 p.m. Jan. 9, 2014 - Mark Hulbert
Statin usefulness questioned, but patent expirations may ease pain 1:02 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Cholesterol drugs: Do you need them, or not? 5:00 a.m. Jan. 8, 2014 - Elizabeth O'Brien
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Dairy company Emmi acquires 50% stake in Mexideli 5:36 a.m. Jan. 3, 2014 - MarketWatch.com
10 stocks for the U.S. economy’s revival in 2014 10:14 a.m. Dec. 27, 2013 - Diana Furchtgott-Roth
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - blogs.marketwatch.com
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Value investing for retirement portfolios 6:01 a.m. Dec. 7, 2013 - Robert Powell
Auxilium shares soar after FDA approves drug for additional use 3:53 p.m. Dec. 6, 2013 - blogs.marketwatch.com
A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease 2:00 p.m. Today - Seeking Alpha
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 6:31 a.m. Today - benzinga.com
Facebook Cements Position Among Most Traded Stocks 6:08 a.m. Today - 247WallSt.com
Pfizer Finds Success With Chantix Clinical Study 7:44 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Is Johnson & Johnson Enticing After Recent Headlines? 5:02 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Will Pfizer Stop-Smoking Pill Hurt Tobacco Giants? 11:14 a.m. Jan. 21, 2014 - 247WallSt.com
Pfizer treatment to stop smoking meets endpoints 10:58 a.m. Jan. 21, 2014 - Seeking Alpha
Pfizer Inc Stock Buy Recommendation Reiterated (PFE) 9:05 a.m. Jan. 21, 2014 - TheStreet.com
ViiV Healthcare's Tivicay Approved in Europe 5:55 a.m. Jan. 21, 2014 - benzinga.com
J&J Needs to Earn Investor Loyalty 1:30 p.m. Jan. 20, 2014 - WSJ.com
Sometimes Leasing a Stock Is Better Than Buying 1:31 p.m. Jan. 17, 2014 - TheStreet.com
Niche REITs Look Cheap 8:02 a.m. Jan. 17, 2014 - Barrons.com
J&J Continues ‘Strategic Pruning’ With This Divestiture 4:08 p.m. Jan. 16, 2014 - Wall St. Cheat Sheet
AstraZeneca: Should You Buy This 4.5% Yielder? 11:56 a.m. Jan. 16, 2014 - Seeking Alpha
Drug Buyouts On The Rise -- But Buyers Changing 5:42 p.m. Jan. 15, 2014 - Investors Business Daily
Can GlaxoSmithKline Break Higher? 5:29 p.m. Jan. 15, 2014 - Wall St. Cheat Sheet
Chevron? Dividend Growth Plus Promising Projects 3:41 p.m. Jan. 15, 2014 - Seeking Alpha
Strategy Update from Merck - Analyst Blog 3:41 p.m. Jan. 15, 2014 - Zacks.com
Where to Find Yield 10:20 a.m. Jan. 15, 2014 - Barrons.com
Pfizer Inc (PFE): Today's Featured Drugs Winner 5:00 p.m. Jan. 14, 2014 - TheStreet.com
Pharmerging Markets 2012-2016 11:12 a.m. Today - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Today - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Today - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease 8:03 a.m. Jan. 9, 2014 - PR Newswire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases 7:59 a.m. Jan. 8, 2014 - BusinessWire
Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda 8:00 a.m. Jan. 1, 2014 - PR Newswire
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Patent Settlements, Stock Price Movements, and Financial Guidance - Research Report on Pfizer, Tenet, Rockwell Medical, Magellan Health Services, and HealthSouth 8:00 a.m. Dec. 20, 2013 - PR Newswire
FDA Accepts For Review ELIQUIS(R) (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE 5:01 p.m. Dec. 19, 2013 - BusinessWire
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Audit: Medicare overpays for penis pumps 6:48 p.m. Jan. 14, 2014 - blogs.marketwatch.com
A contrarian take on the market’s correction 12:48 p.m. Jan. 9, 2014 - Mark Hulbert
Statin usefulness questioned, but patent expirations may ease pain 1:02 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Cholesterol drugs: Do you need them, or not? 5:00 a.m. Jan. 8, 2014 - Elizabeth O'Brien
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Dairy company Emmi acquires 50% stake in Mexideli 5:36 a.m. Jan. 3, 2014 - MarketWatch.com
10 stocks for the U.S. economy’s revival in 2014 10:14 a.m. Dec. 27, 2013 - Diana Furchtgott-Roth
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - blogs.marketwatch.com
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Value investing for retirement portfolios 6:01 a.m. Dec. 7, 2013 - Robert Powell
Auxilium shares soar after FDA approves drug for additional use 3:53 p.m. Dec. 6, 2013 - blogs.marketwatch.com
A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease 2:00 p.m. Today - Seeking Alpha
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 6:31 a.m. Today - benzinga.com
Facebook Cements Position Among Most Traded Stocks 6:08 a.m. Today - 247WallSt.com
Pfizer Finds Success With Chantix Clinical Study 7:44 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Is Johnson & Johnson Enticing After Recent Headlines? 5:02 p.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Will Pfizer Stop-Smoking Pill Hurt Tobacco Giants? 11:14 a.m. Jan. 21, 2014 - 247WallSt.com
Pfizer treatment to stop smoking meets endpoints 10:58 a.m. Jan. 21, 2014 - Seeking Alpha
Pfizer Inc Stock Buy Recommendation Reiterated (PFE) 9:05 a.m. Jan. 21, 2014 - TheStreet.com
ViiV Healthcare's Tivicay Approved in Europe 5:55 a.m. Jan. 21, 2014 - benzinga.com
J&J Needs to Earn Investor Loyalty 1:30 p.m. Jan. 20, 2014 - WSJ.com
Sometimes Leasing a Stock Is Better Than Buying 1:31 p.m. Jan. 17, 2014 - TheStreet.com
Niche REITs Look Cheap 8:02 a.m. Jan. 17, 2014 - Barrons.com
J&J Continues ‘Strategic Pruning’ With This Divestiture 4:08 p.m. Jan. 16, 2014 - Wall St. Cheat Sheet
AstraZeneca: Should You Buy This 4.5% Yielder? 11:56 a.m. Jan. 16, 2014 - Seeking Alpha
Drug Buyouts On The Rise -- But Buyers Changing 5:42 p.m. Jan. 15, 2014 - Investors Business Daily
Can GlaxoSmithKline Break Higher? 5:29 p.m. Jan. 15, 2014 - Wall St. Cheat Sheet
Chevron? Dividend Growth Plus Promising Projects 3:41 p.m. Jan. 15, 2014 - Seeking Alpha
Strategy Update from Merck - Analyst Blog 3:41 p.m. Jan. 15, 2014 - Zacks.com
Where to Find Yield 10:20 a.m. Jan. 15, 2014 - Barrons.com
Pfizer Inc (PFE): Today's Featured Drugs Winner 5:00 p.m. Jan. 14, 2014 - TheStreet.com
Pharmerging Markets 2012-2016 11:12 a.m. Today - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Today - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Today - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease 8:03 a.m. Jan. 9, 2014 - PR Newswire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases 7:59 a.m. Jan. 8, 2014 - BusinessWire
Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda 8:00 a.m. Jan. 1, 2014 - PR Newswire
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Patent Settlements, Stock Price Movements, and Financial Guidance - Research Report on Pfizer, Tenet, Rockwell Medical, Magellan Health Services, and HealthSouth 8:00 a.m. Dec. 20, 2013 - PR Newswire
FDA Accepts For Review ELIQUIS(R) (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE 5:01 p.m. Dec. 19, 2013 - BusinessWire
